NEPHROLOGISTS PERCEIVE THE ANEMIA EFFECTS OF KERYX’S AURYXIA TO BE FAVORABLE, BUT MARKET PENETRATION AT SIX MONTHS POST LAUNCH IS LOW
Familiarity with Auryxia is the primary barrier to adoption and growth, according to Spherix Global Insights, GmbH August 20, 2015 – Zug, Switzerland –RealTime Dynamix: Nephrology reveals that while Keryx contact rates for Auryxia are in line with those of…